Variations in exposure to mitomycin C in an in vitro colony-forming assay. 1986

P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom

The effect of mitomycin C on two human ovarian cancer cell lines was measured during several exposure times and concentrations using the Human Tumour Colony-forming Assay (HTCA). Changes in exposure time and concentration resulted in considerable differences in tumour cell survival. It is concluded that several exposure times and concentrations are necessary for in vitro sensitivity testing. We suggest alternative criteria derived from pharmacokinetic data in patients instead of one-tenth of the peak plasma level which is the usual practice.

UI MeSH Term Description Entries
D008937 Mitomycins A group of methylazirinopyrroloindolediones obtained from certain Streptomyces strains. They are very toxic antibiotics used as ANTINEOPLASTIC AGENTS in some solid tumors. PORFIROMYCIN and MITOMYCIN are the most useful members of the group.
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014410 Tumor Stem Cell Assay A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents. Clonogenic Cell Assay, Tumor,Colony-Forming Units Assay, Tumor,Neoplasm Stem Cell Assay,Stem Cell Assay, Tumor,Colony Forming Units Assay, Tumor

Related Publications

P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
November 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
January 2018, Methods in molecular biology (Clifton, N.J.),
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
October 1968, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
November 1988, Hinyokika kiyo. Acta urologica Japonica,
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
September 1973, Cell and tissue kinetics,
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
November 1985, British journal of cancer,
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
June 1989, British journal of cancer,
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
March 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
December 1973, Journal of the National Cancer Institute,
P H Slee, and E A de Bruijn, and P Leeflang, and P J Kuppen, and L van den Berg, and A T van Oosterom
January 1992, Current topics in microbiology and immunology,
Copied contents to your clipboard!